Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.05 - $1.63 $1,659 - $2,575
-1,580 Reduced 11.63%
12,003 $13,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $14,276 - $32,478
-11,897 Reduced 46.69%
13,583 $18,000
Q4 2022

Feb 14, 2023

SELL
$1.71 - $3.61 $17,542 - $37,034
-10,259 Reduced 28.71%
25,480 $47,000
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $11,696 - $53,126
6,156 Added 20.81%
35,739 $88,000
Q2 2022

Aug 15, 2022

BUY
$2.13 - $9.01 $17,125 - $72,440
8,040 Added 37.32%
29,583 $72,000
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $2.89 Million - $7.17 Million
-459,896 Reduced 95.53%
21,543 $172,000
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $1.28 Million - $2.5 Million
87,218 Added 22.12%
481,439 $7.35 Million
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $8.7 Million - $12 Million
358,039 Added 989.55%
394,221 $11.2 Million
Q2 2021

Aug 16, 2021

BUY
$26.09 - $40.4 $337,161 - $522,089
12,923 Added 55.56%
36,182 $1.22 Million
Q1 2021

May 17, 2021

SELL
$33.06 - $56.93 $962,012 - $1.66 Million
-29,099 Reduced 55.58%
23,259 $888,000
Q4 2020

Feb 12, 2021

SELL
$39.09 - $57.4 $3.42 Million - $5.02 Million
-87,501 Reduced 62.56%
52,358 $2.19 Million
Q3 2020

Nov 16, 2020

BUY
$28.43 - $44.67 $1.17 Million - $1.84 Million
41,136 Added 41.67%
139,859 $6.06 Million
Q2 2020

Aug 14, 2020

SELL
$11.71 - $30.29 $515,497 - $1.33 Million
-44,022 Reduced 30.84%
98,723 $2.99 Million
Q1 2020

May 15, 2020

SELL
$7.64 - $27.5 $900,901 - $3.24 Million
-117,919 Reduced 45.24%
142,745 $1.95 Million
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $6.47 Million - $8.86 Million
-430,576 Reduced 62.29%
260,664 $4.2 Million
Q3 2019

Nov 14, 2019

BUY
$18.85 - $27.5 $8.52 Million - $12.4 Million
451,922 Added 188.84%
691,240 $13.3 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $2.05 Million - $3.09 Million
117,790 Added 96.92%
239,318 $5.62 Million
Q1 2019

May 15, 2019

BUY
$10.65 - $25.75 $1.29 Million - $3.13 Million
121,528 New
121,528 $2.68 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.